Hypotrichosis describes the condition of having thin, light, inadequate eyelashes. Prescription LATISSE™ is a treatment for hypotrichosis used to grow eyelashes, making them longer, thicker and darker.
LATISSE™ (bimatoprost ophthalmic solution) 0.03% is the first and only prescription treatment approved by the FDA for inadequate or insufficient eyelashes, growing them longer, fuller and darker.
LATISSE™ makes lash growth possible because of its active ingredient: bimatoprost. Although the precise mechanism of action if not known, research suggests that the growth of eyelashes occurs by increasing the percent of hairs in, and the duration of, the anagen (or growth) phase. Lashes can grow longer, thicker and darker because bimatoprost can also prolong this growth phase.
LATISSE™ is easy to use, FDA approved and effective. It's a once-a-day treatment you apply topically to the base of your upper eyelashes. Patients in a clinical trial saw results gradually over time (starting at 4 weeks with full results after 16 weeks).
While LATISSE™ is a new treatment in eyelash growth, it was developed through years of research by Allergan, a pharmaceutical leader with over 60 years of expertise in prescription eye care products.
Want to learn more? Call to request information or to schedule a complimentary consultation to learn more about LASTISSE™ with Regional Eye Associates at 304-598-3301 or toll-free, 1-800-598-3301.
For more information about the benefits and risks of Latisse™, click the link below to view the manufacturer's website:
*As with any surgical procedure there are risks along with benefits. It is important to discuss your surgical procedure with your surgeon to fully understand the risks and benefits.